{"transactions":[{"id":964832,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option (right to buy)","published_at":"2025-12-17T18:00:05.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":845226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date."}],"balance_after":845226,"derivative":{"exercise_price":2.24,"expiration_date":"2035-12-14","underlying":"Common Stock","underlying_shares":845226},"source":{"system":"sec-edgar","filing":"0001193125-25-323018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000119312525323018/ownership.xml","form_type":"4"}},{"id":1235595,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option (right to buy)","published_at":"2025-03-03T20:59:55.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":104400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Issuer's initial public offering, on February 1, 2024 the Reporting Person was granted, subject to the satisfaction of certain performance criteria, an option to purchase 174,000 shares of common stock to vest in the form of shares of the Issuer's common stock in four substantially equal installments on December 31, 2024 and each of the first three anniversaries thereof. On February 27, 2025, the Issuer's administrator determined that the performance criteria were partially met, resulting in 104,400 shares subject to such option being earned, of which 25% vested on December 31, 2024 and the remaining 75% will vest in substantially equal installments on the first three anniversaries thereof."}],"balance_after":104400,"derivative":{"exercise_price":15,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":104400},"source":{"system":"sec-edgar","filing":"0000950170-25-031262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025031262/ownership.xml","form_type":"4"}},{"id":1235594,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option (right to buy)","published_at":"2025-03-03T20:59:55.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":179700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal installments on each of the first four anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date."}],"balance_after":179700,"derivative":{"exercise_price":1.46,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":179700},"source":{"system":"sec-edgar","filing":"0000950170-25-031262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025031262/ownership.xml","form_type":"4"}},{"id":1287243,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":false,"shares":22346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":17924,"derivative":{"exercise_price":1.7,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":22346},"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1287242,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":false,"shares":21472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":40270,"derivative":{"exercise_price":1.7,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":21472},"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1287241,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-31","kind":"sale","planned":true,"acquired":false,"shares":22346,"price":1.8108,"value":40464.1368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.8000 to $1.8800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":153544,"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1287240,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":true,"shares":22346,"price":1.7,"value":37988.2,"ownership":{"direct":true},"balance_after":175890,"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1287239,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-30","kind":"sale","planned":true,"acquired":false,"shares":21472,"price":1.9468,"value":41801.6896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.9000 to $2.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":153544,"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1287238,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":true,"shares":21472,"price":1.7,"value":36502.4,"ownership":{"direct":true},"balance_after":175016,"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1366443,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Restricted Stock Unit","published_at":"2024-11-13T18:25:35.000Z","date":"2024-11-10","kind":"exercise","planned":false,"acquired":false,"shares":187257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":187257},"source":{"system":"sec-edgar","filing":"0000950170-24-126558","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024126558/ownership.xml","form_type":"4"}},{"id":1366442,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2024-11-13T18:25:35.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":64197,"price":2.4696,"value":158540.9112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold for tax-withholding purposes due upon the vesting of the restricted stock units."}],"balance_after":153544,"source":{"system":"sec-edgar","filing":"0000950170-24-126558","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024126558/ownership.xml","form_type":"4"}},{"id":1366441,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2024-11-13T18:25:35.000Z","date":"2024-11-10","kind":"exercise","planned":false,"acquired":true,"shares":187257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."}],"balance_after":217741,"source":{"system":"sec-edgar","filing":"0000950170-24-126558","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024126558/ownership.xml","form_type":"4"}},{"id":1407589,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option","published_at":"2024-09-13T18:39:14.000Z","date":"2024-09-12","kind":"exercise","planned":false,"acquired":false,"shares":95484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.7,"expiration_date":"2024-11-10","underlying":"Common Stock","underlying_shares":95484},"source":{"system":"sec-edgar","filing":"0000950170-24-106530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024106530/ownership.xml","form_type":"4"}},{"id":1407588,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2024-09-13T18:39:14.000Z","date":"2024-09-12","kind":"sale","planned":false,"acquired":false,"shares":65000,"price":2.8996,"value":188474.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $2.85 to $3.06. The Reporting Person undertakes to provide upon request the Staff of the Securities and Exchange Commission, the Issuer, or any stockholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":30484,"source":{"system":"sec-edgar","filing":"0000950170-24-106530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024106530/ownership.xml","form_type":"4"}},{"id":1407587,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2024-09-13T18:39:14.000Z","date":"2024-09-12","kind":"exercise","planned":false,"acquired":true,"shares":95484,"price":1.7,"value":162322.8,"ownership":{"direct":true},"balance_after":95484,"source":{"system":"sec-edgar","filing":"0000950170-24-106530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024106530/ownership.xml","form_type":"4"}},{"id":1653273,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Series C-2 Preferred Stock","published_at":"2024-02-08T16:37:24.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":32514,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15150},"source":{"system":"sec-edgar","filing":"0000950170-24-012836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024012836/ownership.xml","form_type":"4"}},{"id":1653272,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Series C-1 Preferred Stock","published_at":"2024-02-08T16:37:24.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":44730,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20843},"source":{"system":"sec-edgar","filing":"0000950170-24-012836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024012836/ownership.xml","form_type":"4"}},{"id":1653271,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Series B Preferred Stock","published_at":"2024-02-08T16:37:24.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":177726,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":82817},"source":{"system":"sec-edgar","filing":"0000950170-24-012836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024012836/ownership.xml","form_type":"4"}},{"id":1653270,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Series A Preferred Stock","published_at":"2024-02-08T16:37:24.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Reporting Person's Form 3 filed on February 1, 2024 inadvertently omitted the securities held by the Jay D. Caplan 2021 Irrevocable Trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":23299},"source":{"system":"sec-edgar","filing":"0000950170-24-012836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024012836/ownership.xml","form_type":"4"}},{"id":1653269,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2024-02-08T16:37:24.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":118810,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."}],"balance_after":118810,"source":{"system":"sec-edgar","filing":"0000950170-24-012836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024012836/ownership.xml","form_type":"4"}},{"id":1653268,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2024-02-08T16:37:24.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":23299,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's Form 3 filed on February 1, 2024 inadvertently omitted the securities held by the Jay D. Caplan 2021 Irrevocable Trust."}],"balance_after":358806,"source":{"system":"sec-edgar","filing":"0000950170-24-012836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024012836/ownership.xml","form_type":"4"}}]}